A clinical trial with sub-cutaneous Plasminogen in patients with diabetic foot ulcers
Phase of Trial: Phase II
Latest Information Update: 28 Mar 2018
At a glance
- Drugs Plasminogen (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- 28 Mar 2018 According to a ProMetic Life Sciences media release, study is being conducted in one study center in Sweden, under the supervision of Dr. Jan Apelqvist,from the Department of Endocrinology, Division of Clinical Sciences at Skane University Hospital in Malmo, Sweden.
- 26 Feb 2018 New trial record
- 20 Feb 2018 According to a ProMetic Life Sciences media release, interim clinical data readouts are expected later this year.